We presume the abnormal lipid metabolism in the retina of apoB100,LDLR
−/− mice is involved in the accumulation of cholesteryl ester at the basement of RPE. The apoB100,LDLR
−/− mouse is an established model for atherosclerosis, in that it shares close features with atherosclerosis in humans: enhanced plasma cholesterol concentrations, aortic fatty streaks,
15 presence of LDL that is almost the exclusive form of cholesterol transport in plasma,
38 and the exclusive expression of human apoB100. Apo-B100 is a large protein that is produced in the liver, where it is assembled into VLDL and remains present in LDL. A commonly recognized role for apoB100 is its capacity to bind LDLR, thereby facilitating internalization of cholesteryl esters from LDL into peripheral cells. The expression of apoB100 in the retina of apoB100,LDLR
−/− mice remains to be shown. Nevertheless, we expect apoB100 to be mainly present in circulating lipoproteins and possibly in the choriocapillaris, as has been reported.
2 39 40 Assuming that LDL can reach RPE
40 41 and LDLR is present in RPE,
41 the lack of LDLR in apoB100,LDLR
−/− animals may abrogate the transfer of cholesterol from circulating LDL into RPE cells, leading to cholesterol deposition. Apart from the interaction of LDLR and apoB100 as a pathway for the transfer of lipid and nutrients to the outer retina, other mechanisms may be suggested, as indicated by the presence of CD36 in the RPE.
39 This pathway may be an alternative route for lipid and nutrients to cross the RPE barrier and target the outer retina, in addition to the lack of LDLR, and may explain the non-null ERG response in apoB100,LDLR
−/− mice, as well as why DHA was not reduced in the neural retina of apoB100,LDLR
−/− mice, since one would expect low DHA levels if lipid transfer from the RPE to the neural retinal was impaired.